Seasons Nursing And Rehab in Stow, OH

Seasons Nursing And Rehab is a medicare and medicaid certified nursing home in Stow, Ohio. It is located in Summit county at 456 Seasons Rd, Stow, Ohio 44224. You can reach out to the office of Seasons Nursing And Rehab via phone at (330) 688-5553. This skilled nursing facility has 50 federally certified beds with average occupancy rate of 86.8%. Its legal business name is Seasons Healthcare Group, Llc and has the following ownership type - For Profit - Corporation.

Seasons Nursing And Rehab (Medicare CCN 366183) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1999 (25 years certified) and the last quality survey was conducted in March, 2020.

Contact Information

Seasons Nursing And Rehab
456 Seasons Rd, Stow, Ohio 44224
(330) 688-5553


Nursing Home Profile

NameSeasons Nursing And Rehab
Location456 Seasons Rd, Stow, Ohio
Certified ByMedicare and Medicaid
No. of Certified Beds50
Occupancy Rate86.8%
Medicare ID (CCN)366183
Legal Business NameSeasons Healthcare Group, Llc
Ownership TypeFor Profit - Corporation

NPI Associated with this Nursing Home:

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Seasons Nursing And Rehab from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1861531881
Organization NameSEASONS HEALTHCARE GROUP, LLC
Doing Business AsTWIN PINES RETREAT CARE CENTER
Address456 Seasons Rd, Stow, OH 44224
Phone Number330-688-5553

News Archive

Heart brain interactions provide a new diagnostic avenue for patients with disorders of consciousness

A new study conducted jointly by the University of Liege (Belgium) and the Ecole normale superieure - PSL (France) shows that heart brain interactions, measured using electroencephalography (EEG), provide a novel diagnostic avenue for patients with disorders of consciousness.

Proteo's Elafin recommended for orphan drug status in Europe

The Committee for Orphan Medical Products (COMP) of the European Medicines Agency (EMEA) has issued a recommendation granting orphan drug status to Proteo's drug candidate Elafin for the treatment of esophagus carcinoma. The orphan drug status will become effective upon ratification of this recommendation by the European Commission.

Vyvanse Capsules CII demonstrates significant improvement in adults with ADHD: Phase 3b study

Shire plc, the global specialty biopharmaceutical company, today announced that a Phase 3b study published in Behavioral and Brain Functions found adults with Attention Deficit Hyperactivity Disorder who took once-daily Vyvanse (lisdexamfetamine dimesylate) Capsules CII demonstrated significant improvement in attention.

New app helps improve the lives of children with asthma

An app that allows parents and doctors to monitor a child's asthma has a big impact on managing the disease.

Read more Medical News

› Verified 8 days ago

Quality Ratings:

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Seasons Nursing And Rehab are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Seasons Nursing And Rehab give to their patients.
Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Heart brain interactions provide a new diagnostic avenue for patients with disorders of consciousness

A new study conducted jointly by the University of Liege (Belgium) and the Ecole normale superieure - PSL (France) shows that heart brain interactions, measured using electroencephalography (EEG), provide a novel diagnostic avenue for patients with disorders of consciousness.

Proteo's Elafin recommended for orphan drug status in Europe

The Committee for Orphan Medical Products (COMP) of the European Medicines Agency (EMEA) has issued a recommendation granting orphan drug status to Proteo's drug candidate Elafin for the treatment of esophagus carcinoma. The orphan drug status will become effective upon ratification of this recommendation by the European Commission.

Vyvanse Capsules CII demonstrates significant improvement in adults with ADHD: Phase 3b study

Shire plc, the global specialty biopharmaceutical company, today announced that a Phase 3b study published in Behavioral and Brain Functions found adults with Attention Deficit Hyperactivity Disorder who took once-daily Vyvanse (lisdexamfetamine dimesylate) Capsules CII demonstrated significant improvement in attention.

New app helps improve the lives of children with asthma

An app that allows parents and doctors to monitor a child's asthma has a big impact on managing the disease.

Read more Medical News

› Verified 8 days ago

Complaints, Fines and Penalties:

Number of Facility Reported Incidents0
Number of Substantiated Complaints0
Number of Fines0
Total Amount of Fines in Dollars$0
Number of Payment Denials1
Total Number of Penalties1

Patients' Stay Experience:

The resident survey data of Seasons Nursing And Rehab is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.
Percentage of long-stay residents whose need for help with daily activities has increased2.4414.46
Percentage of long-stay residents who lose too much weight5.265.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder26.8948.41
Percentage of long-stay residents with a catheter inserted and left in their bladder01.79
Percentage of long-stay residents with a urinary tract infection02.65
Percentage of long-stay residents who have depressive symptoms53.895.05
Percentage of long-stay residents who were physically restrained00.23
Percentage of long-stay residents experiencing one or more falls with major injury3.433.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine96.5793.87
Percentage of long-stay residents who received an antipsychotic medication4014.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine68.1883.88